Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in IONIS PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 1.5M shares of IONS (IONIS PHARMACEUTICALS INC), worth $110.8M as of 2026-Q1. The position was increased (+6.3% shares). IONS represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$110.8M
Current Shares
1.5M
Total Value Change
+$95.5M
Total Shares Change
+1.2M
Other major holders of IONS: BNP PARIBAS FINANCIAL MARKETS
Increased |
| 1.5M |
+6.3% |
| $110.8M |
| 0.0% |
| $78.66 |
32 |
| 2025-Q4 | Increased | 1.4M | +20.3% | $109.8M | 0.0% | $78.97 | 36 |
| 2025-Q3 | Increased | 1.2M | +45.9% | $75.5M | 0.0% | $64.15 | 40 |
| 2025-Q2 | Increased | 791,072 | +20.0% | $31.3M | 0.0% | $39.80 | 34 |
| 2025-Q1 | Increased | 659,435 | +6.4% | $19.9M | 0.0% | $31.15 | 30 |
| 2024-Q4 | Increased | 619,641 | +116.9% | $21.7M | 0.0% | $34.92 | 46 |
| 2024-Q3 | Decreased | 285,697 | -10.8% | $11.4M | 0.0% | $40.85 | 0 |
| 2024-Q2 | Increased | 320,290 | +71.9% | $15.3M | 0.0% | $47.66 | 42 |